BioXcel Therapeutics to Host Virtual Key Opinion Leader Event to Highlight BXCL501 as a ...
Press release content from Globe Newswire. The AP news staff was not involved in its creation. BioXcel Therapeutics to Host Virtual Key Opinion Leader Event to Highlight BXCL501 as a ... BioXcel TherapeuticsFebruary 12, 2021 GMT NEW HAVEN, Conn., Feb. 12, 2021 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (“BioXcel” or the “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced that the Company will host a virtual Key Opinion Leader (“K...